Wells Fargo & Company »

Aligos Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $31k 3.2k 9.80
2025-06-30 $99k 14k 7.21
2025-03-31 $190k 23k 8.25
2024-12-31 $869k 22k 39.84